A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 20
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : VASP
Long Form : vasodilator-stimulated phosphoprotein phosphorylation
No. Year Title Co-occurring Abbreviation
2021 Impact of high on-treatment platelet reactivity after angioplasty in patients with critical limb ischemia. CLI, DAPT, HTPR, LTA, MACCE, MALE, PAD, PTA
2021 Is platelet function testing at the acute phase under P2Y12 inhibitors helpful in predicting bleeding in real-life patients with acute coronary syndrome? The AVALANCHE study. ACS, BARC
2020 Impact of high on-treatment platelet reactivity after angioplasty in patients with peripheral arterial disease. CI, DAPT, HR, HTPR, LTA, MACCE, MALE, PAD
2018 Lethal cerebral hemorrhage after ticagrelor intoxication: a specific antidote is urgently needed. ---
2018 Platelet function testing: dead or alive. HTPR, LTA, LTPR, MP
2018 Switching from clopidogrel to prasugrel to protect early invasive treatment in acute coronary syndromes: Results of the switch over trial. EP, NSTE-ACS, PCI, PD
2015 Antiplatelet effects of clopidogrel and aspirin after interventional patent foramen ovale/ atrium septum defect closure. ASD, HTPR, LTA, PFO
2015 In vitro anti-platelet potency of ticagrelor in blood samples from infants and children. LTA
2015 Platelet reactivity in MitraClip patients. LTA
10  2015 The relationship between on-clopidogrel platelet reactivity, genotype, and post-percutaneous coronary intervention outcomes in Chinese patients. ACS, ADP, MACE, PCI, PRI
11  2014 Detection of clopidogrel resistance using ADP induced aggregometry with specific inhibitor PGE1. CAD, LTA, MEA, PGE1
12  2013 Nuisance and alarming bleeding do not correlate with on-treatment platelet reactivity. ADP
13  2013 Relationship between CYP2C19 loss-of-function polymorphism and platelet reactivities with clopidogrel treatment in Japanese patients undergoing coronary stent implantation. EMs, IMs, PMs
14  2012 Phenotyping vs. genotyping for prediction of clopidogrel efficacy and safety: the PEGASUS-PCI study. CPA, MEA
15  2011 Comparison of the VASP assay and platelet aggregometry in the evaluation of platelet P2Y12 receptor blockade. ADP, AUC, MEA, PRI
16  2011 Correlation between light transmission aggregometry, VerifyNow P2Y12, and VASP-P platelet reactivity assays following percutaneous coronary intervention. ADP, LTA, PCI, PRI
17  2011 Monitoring of antiplatelet therapy. Current limitations, challenges, and perspectives. TXB2
18  2010 Individualised assessment of response to clopidogrel in patients presenting with acute coronary syndromes: a role for short thrombelastography? ACS, AUC15, NSTEMI, s-TEG, UA, VN-RPFA
19  2008 Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel. CAD, PCI, PPI
20  2008 Residual prothrombotic status in low responder patients to clopidogrel identified by Vasodilator-Stimulated Phosphoprotein Phosphorylation (VASP) analysis? ---